How do you decide between starting an intensive remote carbohydrate-reduction program immediately versus prioritizing prompt fibrosis staging (VCTE/MRE) and/or hepatology referral in patients with T2D/obesity, mildly elevated aminotransferases, and an intermediate FIB-4 (e.g., ~1.3–1.7) but no prior liver imaging?